Literature DB >> 8781573

Ten years disease-free survival after solitary brain metastasis from breast cancer.

C Nieder1, K Walter, U Nestle, K Schnabel.   

Abstract

The unique case of a 51-year-old woman who developed a solitary brain metastasis as the first site of systemic disease 11 months after a total mastectomy for an undifferentiated infiltrating ductal carcinoma of her right breast is described. After surgery for the pT2pN0 carcinoma, the patient received radiotherapy of the internal mammary and supraclavicular lymph nodes. The brain metastasis was treated with surgery and adjuvant whole-brain radiotherapy to a total dose of 30 Gy in December 1984 and January 1985. Afterwards a hormonal treatment with tamoxifen was initiated, which still continues. Since then no further distant or lymph node metastases have developed. The patient is under regular after-care and undergoes various apparative examinations every 6 months. She is generally well and suffers only from a postoperatively persistent hemianopsia. This is the first case in which a disease-free survival for more than 10 years after brain metastases from breast cancer has been reported. It illustrates the specific biological behaviour of this tumour type and the chance of achieving long-term survival in very selected cases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781573     DOI: 10.1007/bf01213556

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  16 in total

1.  Intracranial metastases: behavioral patterns related to primary site and results of treatment by whole brain irradiation.

Authors:  J West; M Maor
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-01       Impact factor: 7.038

2.  The natural history of breast cancer patients with brain metastases.

Authors:  A DiStefano; Y Yong Yap; G N Hortobagyi; G R Blumenschein
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

3.  Complete remission of a brain metastasis to third-line hormonal treatment with megestrol acetate.

Authors:  A van der Gaast; J Alexieva-Figusch; C Vecht; J Verweij; G Stoter
Journal:  Am J Clin Oncol       Date:  1990-12       Impact factor: 2.339

Review 4.  The role of radiation therapy in the treatment of brain metastases.

Authors:  L R Coia
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

5.  The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

Authors:  E M Noordijk; C J Vecht; H Haaxma-Reiche; G W Padberg; J H Voormolen; F H Hoekstra; J T Tans; N Lambooij; J A Metsaars; A R Wattendorff
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-07-01       Impact factor: 7.038

6.  Differential influence of prognostic factors on the occurrence of metastases at various anatomical sites in human breast cancer.

Authors:  K Zedeler; N Keiding; C Kamby
Journal:  Stat Med       Date:  1992-02-15       Impact factor: 2.373

7.  Radiotherapy of brain metastases.

Authors:  S Egawa; I Tukiyama; Y Akine; Y Kajiura; S Yanagawa; K Watai; K Nomura
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-09       Impact factor: 7.038

8.  Long-term survival after brain metastases in breast cancer.

Authors:  M Kocher; R P Müller; S Staar; D Degroot
Journal:  Strahlenther Onkol       Date:  1995-05       Impact factor: 3.621

9.  Characteristics of patients with short and long survivals after detection of intracranial metastases from breast cancer.

Authors:  C Kamby; P S Soerensen
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

10.  Brain metastases in breast cancer; natural history, prognostic factors and outcome.

Authors:  W Boogerd; V W Vos; A A Hart; G Baris
Journal:  J Neurooncol       Date:  1993-02       Impact factor: 4.130

View more
  1 in total

1.  Brain metastasis in pancreatic cancer.

Authors:  Johannes Lemke; Jan Scheele; Thomas Kapapa; Christian Rainer Wirtz; Doris Henne-Bruns; Marko Kornmann
Journal:  Int J Mol Sci       Date:  2013-02-19       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.